Peptide Synthesis Market To Grow at CAGR 6.6%, Market Value to Reach USD 400 Million By 2026

The report analyzes and forecasts the Peptide Synthesis Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Peptide Synthesis Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the Peptide Synthesis Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of Peptide Synthesis Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/1617

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

Peptide Synthesis MarketMarket Players as below:

Key players in this market comprise of Bachem Holdings, Biotage, Thermo Fisher, Polypeptide Group, PuroSynth, Syngene, MP Biomedicals, Novo Nordisk A/S, Genscript Biotech, Merck KGaA, etc

The major market segments of Peptide Synthesis Market are as below:

Market By Product

  • Reagents & Consumables
  • Equipment
  • Others

Market By Technology

  • Solid Phase
  • Liquid Phase
  • Hybrid Phase

Market By End-User

  • Therapeutics
  • Diagnosis
  • Research

Ask Query Here: richard@acumenresearchandconsulting.com  or sales@acumenresearchandconsulting.com

Table Of Contents:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Peptide Synthesis
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Peptide Synthesis Market By Product
1.2.2.1. Global Peptide Synthesis Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Peptide Synthesis Market Revenue Share By Product in 2018
1.2.2.3. Reagents & Consumables
1.2.2.4. Equipment
1.2.2.5. Others
1.2.3. Peptide Synthesis Market By Technology
1.2.3.1. Global Peptide Synthesis Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Solid Phase
1.2.3.3. Liquid Phase
1.2.3.4. Hybrid Phase
1.2.4. Peptide Synthesis Market By End-User
1.2.4.1. Global Peptide Synthesis Market Revenue and Growth Rate Comparison By End-User (2015-2026)
1.2.4.2. Therapeutics
1.2.4.3. Diagnosis
1.2.4.4. Research
1.2.5. Peptide Synthesis Market By Geography
1.2.5.1. Global Peptide Synthesis Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Peptide Synthesis Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Peptide Synthesis Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Peptide Synthesis Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Peptide Synthesis Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Peptide Synthesis Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Peptide Synthesis Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Peptide Synthesis Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Peptide Synthesis Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Peptide Synthesis Major Manufacturers in 2018

CHAPTER 4. PEPTIDE SYNTHESIS MARKET BY PRODUCT
4.1. Global Peptide Synthesis Revenue By Product
4.2. Reagents & Consumables
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Equipment
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. PEPTIDE SYNTHESIS MARKET BY TECHNOLOGY
5.1. Global Peptide Synthesis Revenue By Technology
5.2. Solid Phase
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Liquid Phase
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Hybrid Phase
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. PEPTIDE SYNTHESIS MARKET BY END-USER
6.1. Global Peptide Synthesis Revenue By End-User
6.2. Therapeutics
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Diagnosis
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Research
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA PEPTIDE SYNTHESIS MARKET BY COUNTRY
7.1. North America Peptide Synthesis Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Peptide Synthesis Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Peptide Synthesis Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE PEPTIDE SYNTHESIS MARKET BY COUNTRY
8.1. Europe Peptide Synthesis Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Peptide Synthesis Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET BY COUNTRY
9.1. Asia-Pacific Peptide Synthesis Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Peptide Synthesis Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA PEPTIDE SYNTHESIS MARKET BY COUNTRY
10.1. Latin America Peptide Synthesis Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Peptide Synthesis Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET BY COUNTRY
11.1. Middle East & AFRICA Peptide Synthesis Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East & AFRICA Peptide Synthesis Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)
11.5. Rest of Middle East & AFRICA
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-User, 2015 – 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Bachem Holdings
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Biotage
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Thermo Fisher
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Polypeptide Group
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. PuroSynth
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Syngene
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. MP Biomedicals
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Novo Nordisk A/S
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Genscript Biotech
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Merck KGaA
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Other
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Type Portfolio
12.11.5. Key Developments
12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/1617

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Leave a Reply

Your email address will not be published. Required fields are marked *